You just read:

Cannabics Pharmaceuticals Announces Initiation of a Nationwide Clinical Study to Evaluate Antitumor Properties of Cannabinoid Compounds on Primary Cancer Biopsies

News provided by

Cannabics Pharmaceuticals Inc.

Apr 17, 2019, 09:00 ET